The relationship between Cardiotrophin-1 and Troponin-I in coronary arterial bypass grafting on the beating heart: A prospective study

Heart Surgery Forum

Volumn 18, Issue 4, 2015, Pages E146-E150

  Caliskan, Serhat ^a   Besli, Feyzullah ^b   Yildirim, Ahmet ^a   Gungoren, Fatih ^a   Alisir, Mehmet Fethi ^c   Polat, Ufuk ^a   Ozdemir, Bulent ^a   Bicer, Murat ^a  

^a ULUDAG UNIVERSITY   (Turkey)

^b Sanliurfa Mehmet Akif Inan Training and Research Hospital   (Turkey)

^c Bursa State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CARDIOTROPHIN 1; CREATINE KINASE; CREATINE KINASE MB; HEMOGLOBIN; TROPONIN I; BIOLOGICAL MARKER; CYTOKINE;

ADULT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; CREATINE KINASE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OFF PUMP SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; VENOUS BLOOD; BLOOD; CLINICAL TRIAL; CORONARY ARTERY DISEASE; MYOCARDIAL ISCHEMIA; OFF PUMP CORONARY SURGERY; PREVALENCE; REPRODUCIBILITY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; TURKEY;

BIOMARKERS; CORONARY ARTERY BYPASS, OFF-PUMP; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TROPONIN I; TURKEY;

EID: 84941120496     PISSN: 10983511     EISSN: 15226662     Source Type: Journal    
DOI: 10.1532/hsf.1386     Document Type: Article

References (30)

1. Ad N, Snir E, Vidne BA, Golomb E. 1999. Potential preoperative markers for the risk of developing atrial fibrillation after cardiac surgery. Semin Thorac Cardiovasc Surg 11:308-13.
2. Adams JE, Bodor GS, Davila Roman VG, et al. 1993. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 88:101-6.
3. Anand I, McMurray JJ, Whitmore J, et al. 2004. Anemia and its relationship to clinical outcome in heart failure. Circulation 110:149-54.
4. Chaitman BR, Alderman EL, Sheffield LT, et al. 1983. Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation 67:302-7.
5. Cleveland JC Jr, Shroyer AL, Chen AY, Peterson E, Grover FL. 2001. Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. Ann Thorac Surg 72:1282-9.
6. Force T, Hibberd P, Weeks G, et al. 1990. Perioperative myocardial infarction after coronary artery bypass surgery. Clinical significance and approach to risk stratification. Circulation 82:903-12.
7. Freed DH, Borowiec AM, Angelovska T, Dixon IM. 2003. Induction of protein synthesis in cardiac fibroblasts by cardiotrophin-1: integration of multiple signalling pathways. Cardiovasc Res 60:365-75.
8. Freed DH, Moon MC, Borowiec AM, Jones SC, Zahradka P, Dixon IM. 2003. Cardiotrophin- 1: expression in experimental myocardial infarction and potential role in post-MI wound healing. Mol Cell Biochem 254:247-56.
9. Ghosh S, Ng LL, Talwar S, et al. 2000. Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning. Cardiovasc Res 48:440-7.
10. Gillinov AM, Davis EA, Curtis WE, et al. 1991. Cardiopulmonary bypass and the blood-brain barrier. An experimental study. J Thorac Cardiovasc Surg 104:1110-5.
11. Greaves S, Rutherford J, Aranki S, et al. 1996. Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery. Am Heart J 132:572-3.
12. Hishinuma S, Funamoto M, Fujio Y, Kunisada K, Yamauchi-Takihara K. 1999. Hypoxic stress induces cardiotrophin-1 expression in cardiac myocytes. Biochem Biophys Res Commun 264:436-40.
13. Katus HA1, Remppis A, Neumann FJ, et al. 1991. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 83:902-12.
14. Khan SQ, Kelly D, Quinn P, Davies JE, Ng LL. 2006. Cardiotrophin-1 predicts death or heart failure following acute myocardial infarction. J Card Fail 12:635-40.
15. Luciani N, Nasso G, Gaudino M, et al. 2003. Coronary artery bypass grafting in type II diabetic patients: a comparison between insulindependent and non-insulin-dependent patients at short- and mid-term follow-up. Ann Thorac Surg 76:1149-54.
16. Marui A, Kimura T, Tanaka S, et al. 2012. CREDO-Kyoto Investigators. Comparison of frequency of postoperative stroke in off-pump coronary artery bypass grafting versus on-pump coronary artery bypass grafting versus percutaneous coronary intervention. Am J Cardiol 15:1773-8.
17. Onat A. 2001. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 156:1-10.
18. Richards AM. 2000. Cardiotrophin-1: a new cardiac marker? Clin Sci (Lond) 99:91-2.
19. Roberts R, Henry PD, Witteeveen SA, Sobel BE. 1974. Quantification of serum creatine phosphokinase izoenzyme activity. Am J Cardiol 33:350-54.
20. Sauer H, Neukirchen W, Rahimi G, Grünheck F, Hescheler J, Wartenberg M. 2004. Involvement of reactive oxygen species in cardiotrophin-1 induced proliferation of cardiomyocytes differentiated from murine embryonic stem cells. Exp Cell Res 294:313-24.
21. Smith PLC. 1988. The cerebral consequences of coronary artery bypass surgery. R Coll Surg Eng 70:212-6.
22. Stroobant N, Van Nooten G, Van Belleghem Y, Vingerhoets G. 2005. Relation between neurocognitive impairment, embolic load, and cerebrovascular reactivity following on- and off-pump coronary artery bypass grafting. Chest 127:1967-76.
23. Talwar S, Squire IB, Downie PF, Davies JE, Ng LL. 2000. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84:421-4.
24. Talwar S, Squire IB, O'Brien RJ, Downie PF, Davies JE, Ng LL. 2002. Plasma cardiotrophin-1 following acute myocardial infarction: relationship with left ventricular systolic dysfunction. Clin Sci (Lond) 102:9-14.
25. Talwar S, Squire IB, Downie PF, O'Brien RJ, Davies JE, Ng LL. 2000. Elevated circulating cardiotrophin-1 in heart failure: relationship with parameters of left ventricular systolic dysfunction. Clin Sci (Lond) 99:83-8
26. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. 2012. Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J 33:2551-67.
27. Tian Y, Ruan X, Laurikka J, Laine S, Tarkka M, Wei M. 2011. The human heart releases cardiotrophin-1 after coronary artery bypass grafting with cardiopulmonary bypass. Scand Cardiovasc J 45:252-6
28. Tsutamoto T, Asai S, Tanaka T, et al. 2007. Plasma level of cardiotrophin-1 as a prognostic predictor in patients with chronic heart failure. Eur J Heart Fail 9:1032-7.
29. Wei M, Ren S, Liu J, Li P, Qian H, Tarkka M. 2008. Perioperative plasma brain natriuretic peptide and cardiotrophin-1 in off-pump coronary artery bypass. Scand Cardiovasc J 42:399-404.
30. Wen TC, Rogido MR, Moore JE, Genetta T, Peng H, Sola A. 2005. Cardiotrophin-1 protects cortical neuronal cell against free radical-induced injuries in vitro. Neurosci Lett 387:38-42.